0001415889-24-009205.txt : 20240327
0001415889-24-009205.hdr.sgml : 20240327
20240327162410
ACCESSION NUMBER: 0001415889-24-009205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240326
FILED AS OF DATE: 20240327
DATE AS OF CHANGE: 20240327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RALLIS CHRIS A
CENTRAL INDEX KEY: 0001185945
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32295
FILM NUMBER: 24791044
MAIL ADDRESS:
STREET 1: C/O TENAX THERAPEUTICS, INC.
STREET 2: ONE COPLEY PARKWAY, SUITE 490
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001211583
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (919) 636-4530
MAIL ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20140903
FORMER COMPANY:
FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC
DATE OF NAME CHANGE: 20021223
4
1
form4-03272024_080358.xml
X0508
4
2024-03-26
0001211583
FENNEC PHARMACEUTICALS INC.
FENC
0001185945
RALLIS CHRIS A
C/O FENNEC PHARMACEUTICALS, INC.
PO BOX 13628, 68 TW ALEXANDER DRIVE
RESEARCH TRIANGLE PARK
NC
27709
true
false
false
false
1
Common Shares
2024-03-26
4
S
0
2114
10.97
D
40920
D
Common Shares
2024-03-26
4
M
0
4329
2.31
A
45249
D
Common Shares
2.31
2024-03-26
4
M
0
4329
2.31
D
2014-04-24
2024-04-25
Options
4239
182983
D
Shares sold to satisfy tax obligation on option exercise.
Shares acquired through the exercise of an option pusuant to a 10b5-1 plan adopted on August 17, 2023.
Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.
/s/ Chris A. Rallis
2024-03-27